PT  - JOURNAL ARTICLE
AU  - Hayashi, Takuma
AU  - Yaegashi, Nobuo
AU  - Konishi, Ikuo
TI  - COVID-19 era, Preventive effect of no going out against co-infection of the seasonal influenza virus and SARS-CoV-2
AID  - 10.1101/2020.09.27.20202739
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.27.20202739
4099  - http://medrxiv.org/content/early/2020/10/02/2020.09.27.20202739.short
4100  - http://medrxiv.org/content/early/2020/10/02/2020.09.27.20202739.full
AB  - In the situation where expansion of coronavirus infectious disease-2019 (COVID-19) does not stop, there is concern about co-infection of people with the seasonal influenza infections from late autumn to winter 2020. Therefore, the importance of supplying vaccines against the seasonal influenza has been pointed out all over the world. As an example in Japan, the number of people infected with the seasonal influenza, hand-foot-and-mouth disease (HFMD), epidemic keratoconjunctivitis, and pharyngoconjunctival fever (PCF), which are the seasonal infectious diseases in the 2020 season, has decreased remarkably compared to the number of people infected each year. It is believed that the significant reduction in the number of people infected with these seasonal infectious diseases is a result of the pervasive hand washing, wearing masks and maintaining social distance in COVID-19 rea. To examine the correlation between the three factors of the number of people with each seasonal infectious disease, the mask wearing rate, and the outing rate, we created a three-dimensional scatter plot based on these three factors using principal component analysis. Our research findings demonstrated preventive effect of no going out against co-infection with the seasonal influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported in part by grants from the Japan Ministry of Education, Culture, Science and Technology (No. 24592510, No. 15K1079, and No. 19K09840)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We show the provided approval as followings. AP0000151756 AP0000151757 AP0000151769 AP0000351128 The content of this paper does not include the results of clinical studies or clinical trials.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe show a statement regarding the availability of all data referred to in the manuscript. https://www.metro.tokyo.lg.jp/english/topics/2020/0128_00.html http://idsc.tokyo-eiken.go.jp/assets/weekly/2020/33e.pdf https://stopcovid19.metro.tokyo.lg.jp/en https://corporate-web.agoop.net/pdf/covid-19/agoop_analysis_coronavirus.pdf